Literature DB >> 9605127

Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice.

A J Szalai1, F W van Ginkel, S A Dalrymple, R Murray, J R McGhee, J E Volanakis.   

Abstract

In vitro, IL-6 is the main inducer of the human C-reactive protein (CRP) gene, and IL-1 and steroids can enhance this effect. However, in mice, IL-6 is necessary but not sufficient for induction of the human CRP transgene, and testosterone is required for its constitutive expression by males. To examine the relative contributions of testosterone and IL-6 in the regulation of CRP gene expression, we produced CRP-transgenic (CRPtg), IL-6-deficient (IL-6-/-) mice. Male CRPtg/IL-6-/- mice expressed CRP constitutively, but CRP levels were not increased after injection of LPS. However, acute-phase CRP levels were attained after injection of IL-6. In contrast, female CRPtg/IL-6-/- mice did not express CRP constitutively or after administration of LPS, IL-6, IL-1, or IL-6 plus IL-1. Like males, testosterone-treated CRPtg/IL-6-/- females expressed CRP constitutively, and their transgene responded to injection of IL-6. The endogenous acute-phase protein serum amyloid P (SAP) was expressed constitutively equally by male and female IL-6-/- mice, responded minimally to LPS, and did not respond to either IL-6 or IL-1 alone. Acute-phase levels of SAP were induced in IL-6-/- mice by injection of IL-6 together with IL-1 or LPS. We conclude that in vivo, both constitutive and IL-6-dependent acute-phase expression of the CRP transgene require testosterone. In contrast, testosterone is not required for expression of the SAP gene, which requires IL-1 plus IL-6 for acute-phase induction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605127

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  C-reactive protein-mediated vascular injury requires complement.

Authors:  Fadi G Hage; Suzanne Oparil; Dongqi Xing; Yiu-Fai Chen; Mark A McCrory; Alexander J Szalai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-03-25       Impact factor: 8.311

2.  C-reactive protein exacerbates renal ischemia-reperfusion injury: are myeloid-derived suppressor cells to blame?

Authors:  Melissa A Pegues; Ian L McWilliams; Alexander J Szalai
Journal:  Am J Physiol Renal Physiol       Date:  2016-04-06

3.  Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice.

Authors:  A J Szalai; J L VanCott; J R McGhee; J E Volanakis; W H Benjamin
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 4.  C-reactive protein, inflammation, and innate immunity.

Authors:  R F Mortensen
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

5.  Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice.

Authors:  Gideon M Hirschfield; J Ruth Gallimore; Melvyn C Kahan; Winston L Hutchinson; Caroline A Sabin; G Martin Benson; Amar P Dhillon; Glenys A Tennent; Mark B Pepys
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-26       Impact factor: 11.205

6.  C-reactive protein exacerbates renal ischemia-reperfusion injury.

Authors:  Melissa A Pegues; Mark A McCrory; Abolfazl Zarjou; Alexander J Szalai
Journal:  Am J Physiol Renal Physiol       Date:  2013-03-27

7.  Transgenic mice showing inflammation-inducible overexpression of granulocyte macrophage colony-stimulating factor.

Authors:  B Burke; A Pridmore; N Harraghy; A Collick; J Brown; T Mitchell
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

8.  C-reactive protein induces expression of tissue factor and plasminogen activator inhibitor-1 and promotes fibrin accumulation in vein grafts.

Authors:  Y Ji; P M Fish; T L Strawn; A W Lohman; J Wu; A J Szalai; W P Fay
Journal:  J Thromb Haemost       Date:  2014-08-23       Impact factor: 5.824

9.  Extra-hepatic cancer represses hepatic drug metabolism via interleukin (IL)-6 signalling.

Authors:  Marina Kacevska; Andre Mahns; Rohini Sharma; Stephen J Clarke; Graham R Robertson; Christopher Liddle
Journal:  Pharm Res       Date:  2013-04-20       Impact factor: 4.200

Review 10.  Pattern recognition by pentraxins.

Authors:  Alok Agrawal; Prem Prakash Singh; Barbara Bottazzi; Cecilia Garlanda; Alberto Mantovani
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.